In vivo: Reduces atherosclerosis in LDLR−/− and ApoE−/− mice. Reduces VCAM-1 mRNA levels in the lungs of LPS-stimulated mice (150 mg/kg/day). This evidence concerns the gene APOE and atherosclerosis.